Genentech Could Get More Clinical Funds From Roche, Less U.S. Taxes
Executive Summary
Roche is offering Genentech more direct clinical development funding for projects that the Swiss parent company decides to accept for co-marketing worldwide, according to a June 14 Genentech "S-3" offering on the re-issue of public shares.